A study of ruxolitinib cream in patients with lichen planus indicated that the topical JAK inhibitor is a promising potential ...

Lipella Pharmaceuticals’ innovative liposomal drug delivery platform receives US patent: Pittsburgh Wednesday, October 16, 2024, 17:00 Hrs [IST] Lipella Pharmaceuticals Inc., a ...

A collection-based survey of lichen species at the Mars Desert Research Station in Utah, USA and Flashline Mars Arctic Research Station in Nunavut, Canada was conducted as part of the Mars-160 mission ...

With the recent patent allowance and ongoing clinical trials, Lipella Pharmaceuticals is poised for significant advancements in its therapeutic offerings. The company’s focus on conditions with high ...

Patent application covers key technology innovations for delivering therapeutic agentsProprietary technology enables precise ...

Once you know where to look for them, lichens are everywhere. These composite organisms—fungal and photosynthetic partners ...

It is important to get tested regularly and to practice safer sex, including the use of condoms. Oral lichen planus is a condition that appears in the mouth. It stems from lichen planus, a chronic ...

Lichen planus, particularly in its oral form, is associated with a small increased risk of developing oral cancer. Lichen planus is a chronic condition that affects the skin and mucous membranes ...

Dr. Michael Chancellor, Chief Medical Officer of Lipella Pharmaceuticals, commented, “Oral Lichen Planus is a highly disruptive condition that significantly impacts patients’ daily lives. Given the ...

Dr. Michael Chancellor, Chief Medical Officer of Lipella Pharmaceuticals, commented, "Oral Lichen Planus is a highly disruptive condition that significantly impacts patients' daily lives.